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It is an intuitive notion that a highly organised multicomponent system, such as the cell, 
requires mechanisms and machinery to establish, maintain, and adapt its organisation to 
meet functional requirements. Yet, we still have only a fragmented understanding of how this 
works. This special issue doesn’t attempt to provide a comprehensive overview of this vast 
topic covering several fields but aims to provide snapshots of the interests and visions of 
several scientists, who are, or are poised to emerge as, leaders in this area of research.  
 
We are now used to the idea that a cell is like a city - there is a transport network, much like 
roads or railways (the cytoskeleton), upon which cargo carrying vehicles (molecular motors) 
can move to transport cellular components to the right place at the right time. Indeed, 
something in that vein is typically found in the lay summaries of this editor’s grant 
applications. Building on that analogy, the transport network requires renewal, maintenance 
and repair to limit broken rails, potholes and defective vehicles. Twelvetrees considers this 
problem in the neuron where it is perhaps most prescient. How is a microtubule transport 
system with nanoscale components maintained on the macroscopic scale of the axon that 
can be up to 1 meter long, with only limited capacity for local protein synthesis? Focusing on 
the tubulin proteins, cytoplasmic dynein and kinesin-1, the author asks where the 
components are synthesised and complex molecular machines assembled, how they are 
moved to the right place in the axon and prevented from running amok before they get there 
and how are they degraded when not required? It is also becoming clear that motors can 
damage their tracks; how are those potholes repaired? The implications for our 
understanding of neuronal health and neurodegeneration are clear. 
 
Webb, Mukhopadhyay, and Roberts consider another microtubule-based system and its 
motors – intraflagellar transport (IFT) in the primary cilium, where questions related to those 
posed above are being answered at a remarkable atomic level of detail, informing our 
understanding of their function at the cellular level. The authors review significant recent 
progress driven by advances in single particle cryo-electron microscopy and cryo-electron 
tomography on the molecular architecture of the IFT machinery. They consider the 
coordination of teams of dynein-2 and kinesin-2 motors to  direct transport from the cilium 
base to the tip and back again, discussing how switches in direction might be triggered. This 
work has important implications for understanding the ciliopathies that can result from 
dynein-2 mutations. 
 
Nazockdast and Redemann describe the equally important mechanical role of the 
microtubule cytoskeleton in the mitotic spindle.  They consider the origin and propagation of 
the forces important for spindle self-organisation, chromosome alignment and segregation, 
by considering roles of molecular motors of the dynein and kinesin families, assembly and 
disassembly of microtubules and their intrinsic elastic properties and interaction with the 
wider cellular milieu. The authors highlight how the integration of light microscopy and 
electron tomography with computational modelling promises to provide a complete model 
of spindle formation and function. This might be important for a full understanding of how 
these mechanisms are and can be further targeted in cancer. 
 
Moving away from microtubules, their associated proteins, and molecular machines, Carroll 
provides a perspective on the spatial organisation of cellular signalling pathways, focusing on 
the rapamycin complex 1 (mTORC1) kinase which controls cell growth and metabolism. I am 
tempted at this point to over-extend the city transport analogy with talk of fuel gauges, but 
I’ll refrain. Nonetheless, it is now very well established that mTORC1 localises to lysosomes 
where it encounters its activator Rheb in a process regulated by amino acid and growth factor 
signalling. Perhaps less well appreciated outside of the field, is the proposition that mTORC1 
can function at many other sites including the Golgi apparatus, plasma membrane, 
endosomes and the endoplasmic reticulum and indeed even at inter-organelle contact sites 
between some of these compartments and lysosomes. This begins to provide answers the 
question: where is mTOR? Spatial regulation of activity gives the potential for a refined 
response to signalling inputs and to generate outputs that specifically meet functional 
requirements. It is conceivable that through improved understanding of these ‘off lysosome’ 
mTORC1 pathways, it could be better targeted in cancer and diseases of age. 
 
Finally, Stalder and Gershlick consider sorting at the Golgi and trafficking to the plasma 
membrane. They elegantly and comprehensively bring us up to date on current knowledge, 
and highlight where we still have a much to learn about the molecular machinery that enables 
the generation of an increasingly appreciated wide range of carriers and routes from the 
Golgi, and how dysregulation of secretion may contribute to pathology. 
 
It seems worth adding my own (arguably still fairly new) lab’s take on one potentially useful 
direction of travel. All the authors in this issue provide fundamental molecular level 
mechanistic insights into aspects of cellular organisation. Perhaps, what is less common, is to 
use this information to ask whether we can devise new means of acutely manipulating these 
systems. This is relevant, in part, because of many direct connections to human disease, and 
therefore a potential to develop therapeutics.  However, this does not have to be at the level 
of drug discovery which typically requires resources beyond that of most academic labs. Our 
deep understanding of these proteins and systems can give us an edge in developing assays 
that enable the discovery or design of reagents that highlight the mechanisms that have the 
potential to be drug targets and produce useful tools that lead to the next advances in 
understanding. In doing so, we can help to bridge the gap between the fundamentals of 
cellular organisation, its role in disease, and begin to apply that knowledge towards health 
and wellbeing. 
 
 
 
 
 
 
